BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34792716)

  • 1. Aberrant Methylation of 21 MicroRNA Genes in Breast Cancer: Sets of Genes Associated with Progression and a System of Markers for Predicting Metastasis.
    Loginov VI; Burdennyy AM; Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Karpukhin AV; Khodyrev DS; Braga EA
    Bull Exp Biol Med; 2021 Nov; 172(1):67-71. PubMed ID: 34792716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized Marker System for Early Diagnosis of Breast Cancer.
    Burdennyy AM; Filippova EA; Khodyrev DS; Pronina IV; Lukina SS; Ivanova NA; Kazubskaya TP; Loginov VI; Braga EA
    Bull Exp Biol Med; 2021 Nov; 172(1):57-62. PubMed ID: 34791555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.
    Loginov VI; Pronina IV; Filippova EA; Burdennyy AM; Lukina SS; Kazubskaya TP; Uroshlev LA; Fridman MV; Brovkina OI; Apanovich NV; Karpukhin AV; Stilidi IS; Kushlinskii NE; Dmitriev AA; Braga EA
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marker Systems Based on MicroRNA Gene Methylation for the Diagnosis of Stage I-II Breast Cancer.
    Braga EA; Filippova EA; Loginov VI; Pronina IV; Burdennyi AM; Kazubskaya TP; Fridman MV; Khodyrev DS; Kushlinskii NE
    Bull Exp Biol Med; 2019 Dec; 168(2):280-284. PubMed ID: 31782000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the Level of Methylation of a Group of microRNA Genes as a Factor in the Development and Progression of Non-Small Cell Lung Cancer.
    Gubenko MS; Loginov VI; Burdennyy AM; Pronina IV; Kazubskaya TP; Pertsov SS
    Bull Exp Biol Med; 2022 Dec; 174(2):254-258. PubMed ID: 36598670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Methylation of a Group of microRNA Genes in the Pathogenesis of Metastatic Renal Cell Carcinoma.
    Ivanova NA; Burdennyi AM; Lukina SS; Filippova EA; Pronina IV; Karpukhin AV; Matveev VB; Kazubskaya TP; Loginov VI; Braga EA; Kushlinskii NE
    Bull Exp Biol Med; 2023 Jun; 175(2):249-253. PubMed ID: 37466853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
    Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
    Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer].
    Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E
    Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
    PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant DNA methylation of integrin α4 in human breast cancer.
    Do SI; Ko E; Kang SY; Lee JE; Nam SJ; Cho EY; Kim DH
    Tumour Biol; 2014 Jul; 35(7):7079-84. PubMed ID: 24756760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of the Levels of microRNA Gene Methylation with the Level of Their Expression and Pathomorphological Characteristics of Breast Cancer.
    Filippova EA; Pronina IV; Lukina SS; Kazubskaya TP; Braga EA; Burdennyi AM; Loginov VI
    Bull Exp Biol Med; 2021 Oct; 171(6):764-769. PubMed ID: 34705180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma.
    Braga EA; Loginov VI; Filippova EA; Burdennyi AM; Pronina IV; Kazubskaya TP; Khodyrev DS; Utkin DO; Kushlinskii DN; Adamyan LV; Kuslinskii NE
    Bull Exp Biol Med; 2018 Dec; 166(2):253-256. PubMed ID: 30488208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between promoter hypermethylation of the DACT2 gene and tumor stages in breast cancer.
    Marusa Borgonio-Cuadra V; Miranda-Duarte A; Rojas-Toledo X; Garcia-Hernandez N; Alfredo Sierra-Ramirez J; Cardenas-Garcia M; Elena Hernandez-Caballero M
    J BUON; 2018; 23(2):361-365. PubMed ID: 29745077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer.
    Braga EA; Loginov VI; Burdennyi AM; Filippova EA; Pronina IV; Kurevlev SV; Kazubskaya TP; Kushlinskii DN; Utkin DO; Ermilova VD; Kushlinskii NE
    Bull Exp Biol Med; 2018 Jan; 164(3):351-355. PubMed ID: 29313235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation profiles of miR34 gene family in Vietnamese patients suffering from breast and lung cancers.
    Lan VTT; Son HV; Trang VL; Trang NT; Phuong NT; Toan NL; Duong PAT
    Mol Med Rep; 2018 Aug; 18(2):2476-2484. PubMed ID: 29916548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated, estrogen receptor-positive, lymph node-positive breast cancer patients.
    Dietrich D; Krispin M; Dietrich J; Fassbender A; Lewin J; Harbeck N; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Spyratos F; Foekens JA; Lesche R; Martens JW
    BMC Cancer; 2010 Jun; 10():247. PubMed ID: 20515469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation signature of lymph node metastases in breast cancer patients.
    Barekati Z; Radpour R; Lu Q; Bitzer J; Zheng H; Toniolo P; Lenner P; Zhong XY
    BMC Cancer; 2012 Jun; 12():244. PubMed ID: 22695536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.